Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vascular Endothelial Growth Factor”

403 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 403 results

Not applicableStudy completedNCT02474225
What this trial is testing

Intraocular Pressure Change Following Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agent

Who this might be right for
Intraocular Pressure
Prince of Songkla University 70
Not applicableStudy completedNCT03419572
What this trial is testing

Non-interventional Study of Cabozantinib in Adults With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Ipsen 689
Testing effectiveness (Phase 2)Study completedNCT00827372
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Inhibition in Patients With Unilateral Upper Extremity Lymphedema Following Treatment for Cancer

Who this might be right for
Lymphedema
Kathy Miller 10
Post-approval studies (Phase 4)Study completedNCT01027481
What this trial is testing

Ranibizumab in Patients With Branch Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Medical University of Vienna 30
Early research (Phase 1)Study completedNCT00749021
What this trial is testing

Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments

Who this might be right for
Retinal Pigment Epithelial Detachment
Clement K. Chan 40
Not applicableLooking for participantsNCT07249216
What this trial is testing

Identification of Molecular Signals in Vitreous Humor Associated With Suboptimal Response to Vascular Endothelial Growth Factor (VEGF) Inhibition in Neovascular Age-related Macular Degeneration (nAMD) Within a Clinical Trial Setting

Who this might be right for
Age Related Macular Degeneration
Singapore National Eye Centre 117
Testing effectiveness (Phase 2)WithdrawnNCT00908219
What this trial is testing

Bevacizumab to Prevent Malignant Ascites

Who this might be right for
Malignant Ascites
Baylor College of Medicine
Not applicableStudy completedNCT04970251
What this trial is testing

Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular Glaucoma

Who this might be right for
Intraocular PressureNeovascular GlaucomaVascular Endothelial Growth Factor Overexpression+1 more
Siriraj Hospital 5
Not applicableStudy completedNCT00446381
What this trial is testing

Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema)

Who this might be right for
Proliferative Diabetic RetinopathyDiabetic Macular Edema
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 28
Not applicableStudy completedNCT00834028
What this trial is testing

Recurrence and Distant Metastases in Hepatocellular Carcinoma Treated by Transcatheter Arterial Chemoembolization

Who this might be right for
Hepatocellular Carcinoma
Kaohsiung Medical University Chung-Ho Memorial Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT02348359
What this trial is testing

X-82 to Treat Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration (AMD)Macular DegenerationExudative Age-related Macular Degeneration+5 more
Tyrogenex 157
Not applicableUnknownNCT04902690
What this trial is testing

The Possible Neuroprotective Effect of Ocrelizumab Via VEGF Protein Expression in Relapsing Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis Relapse
IRCCS National Neurological Institute "C. Mondino" Foundation 21
Not applicableStudy completedNCT06881433
What this trial is testing

Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without HAIC for Unresectable HCC With Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhongda Hospital 1,649
Early research (Phase 1)Study completedNCT01916447
What this trial is testing

A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors.

Who this might be right for
Advanced Gastrointestinal Tumors
Taiho Oncology, Inc. 65
Not applicableStudy completedNCT04523844
What this trial is testing

Brinzolamide-brimonidine Fixed Combination for Preventing IOP Elevation After Intravitreal Anti-VEGF Injections

Who this might be right for
Eye DiseasesInjection ComplicationIntraocular Pressure
General Hospital of Athens Elpis 47
Testing effectiveness (Phase 2)Looking for participantsNCT06827236
What this trial is testing

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Who this might be right for
Locally Advanced Breast CancerUnresectable Breast CarcinomaMetastatic Breast Cancer
BioNTech SE 380
Testing effectiveness (Phase 2)Study completedNCT02447679
What this trial is testing

Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence

Who this might be right for
Adult Hepatocellular CarcinomaRecurrent Hepatocellular CarcinomaAdverse Reaction to Drug+1 more
Chang Gung Memorial Hospital 40
Not applicableStudy completedNCT02750956
What this trial is testing

Endocan, VEGF and TNF-alpha Levels in Periodontal Disease and After Treatment

Who this might be right for
Periodontal Disease
Bulent Ecevit University 40
Early research (Phase 1)Study completedNCT03387566
What this trial is testing

Single Intravitreal Injection HB002.1M in Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Huabo Biopharm Co., Ltd. 21
Not applicableStudy completedNCT03793400
What this trial is testing

Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor

Who this might be right for
Choroidal NeovascularizationPunctate Inner Choroidopathy
Changhua Christian Hospital 22
Load More Results